Consensus enVVeno Medical Corporation

Equities

NVNO

US29415J1060

Market Closed - Nasdaq Other stock markets 01:30:00 17/05/2024 am IST			5-day change	1st Jan Change
4.95 ^USD	-1.00%		-2.94%	-3.70%

08/05	EnVVeno Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	EnVVeno Medical Corporation Announces Additional Topline Efficacy Data from the VenoValve U.S. Pivotal Trial to Be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024	CI

Evolution of the average Target Price on enVVeno Medical Corporation

Price target over the last 5 years

History of analyst recommendation changes

39d40e352e10aa2cd4a6.kxkagqccM9fo44DmVp8dgzef7iplWjDPAflJb_zI6q4.9ihj1u4rZeOJrOu5E6lI6FDKrEhTNV6BNpsWJb6w2dbfeFK35ktivYmx4w~cde70e6985e9f63ef6bb3bb2b5d8d4ac

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.95 USD

Average target price

20.4 USD

Spread / Average Target

+312.12%

High Price Target

20.4 USD

Spread / Highest target

+312.12%

Low Price Target

20.4 USD

Spread / Lowest Target

+312.12%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar